Trending Stories

Insights and updates

New data from TAR-200 Phase 2b SunRISe-1 study show 84 percent complete response rate in patients with high-risk non-muscle-invasive bladder cancer

[ad_1] Investigational TAR-200 monotherapy demonstrates high complete response rate without the need for reinduction or additive therapy in patients who are Bacillus Calmette-Guérin (BCG)-unresponsive BARCELONA, Spain, Sept. 15, 2024 /PRNewswire/ — Johnson & Johnson (NYSE:JNJ) announced today […]

Insights and updates

At Congressional Black Caucus Foundation’s Phoenix Awards, President Biden And Vice President Harris Urge Caucus To Advance Their Vision For The Future Ahead Of The Presidential Election.

[ad_1] As he was honored with the CBC Lifetime Achievement award at the Annual Phoenix Awards Dinner, the flagship event of the CBCF’s Annual Legislative Conference, President Biden noted that his administration’s achievements were bolstered […]